Literature DB >> 31449970

Identification of novel TGF-β regulated genes with pro-migratory roles.

Qi Liu1, Nicholas Borcherding2, Peng Shao1, Huojun Cao3, Weizhou Zhang2, Hank Heng Qi4.   

Abstract

Transforming growth factor-β (TGF-β) signaling plays fundamental roles in the development and homeostasis of somatic cells. Dysregulated TGF-β signaling contributes to cancer progression and relapse to therapies by inducing epithelial-to-mesenchymal transition (EMT), enriching cancer stem cells, and promoting immunosuppression. Although many TGF-β-regulated genes have been identified, only a few datasets were obtained by next-generation sequencing. In this study, we performed RNA-sequencing analysis of MCF10A cells and identified 1166 genes that were upregulated and 861 genes that were downregulated by TGF-β. Gene set enrichment analysis revealed that focal adhesion and metabolic pathways were the top enriched pathways of the up- and downregulated genes, respectively. Genes in these pathways also possess significant predictive value for renal cancers. Moreover, we confirmed that TGF-β induced expression of MICAL1 and 2, and the histone demethylase, KDM7A, and revealed their regulatory roles on TGF-β-induced cell migration. We also show a critical effect of KDM7A in regulating the acetylation of H3K27 on TGF-β-induced genes. In sum, this study identified novel effectors that mediate the pro-migratory role of TGF-β signaling, paving the way for future studies that investigate the function of MICAL family members in cancer and the novel epigenetic mechanisms downstream TGF-β signaling.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  Epigenetics; KDM7A/JHDM1D; MICAL1; Migration; TGF-β

Mesh:

Substances:

Year:  2019        PMID: 31449970     DOI: 10.1016/j.bbadis.2019.165537

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Basis Dis        ISSN: 0925-4439            Impact factor:   5.187


  2 in total

1.  TGF-β1-induced bone marrow mesenchymal stem cells (BMSCs) migration via histone demethylase KDM6B mediated inhibition of methylation marker H3K27me3.

Authors:  Qiting He; Jie Shi; Wei Liu; Wei Zhao; Zihao Wang; Kaiwen Liu; Dawang Zhao; Shaoyi Wang; Yongyuan Guo; Lei Cheng; Yuan Gao
Journal:  Cell Death Discov       Date:  2022-07-28

2.  The Jumonji Domain-Containing Histone Demethylase Homolog 1D/lysine Demethylase 7A (JHDM1D/KDM7A) Is an Epigenetic Activator of RHOJ Transcription in Breast Cancer Cells.

Authors:  Ziyu Zhang; Baoyu Chen; Yuwen Zhu; Tianyi Zhang; Yibiao Yuan; Xiaoling Zhang; Yong Xu
Journal:  Front Cell Dev Biol       Date:  2021-06-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.